Primary Outcome Measures:
- Visual Analogic Scale, by clinical examination and opinion of the investigator. [ Time Frame: 3 days ]
Secondary Outcome Measures:
- Of adverse events related to study medication by the Naranjo Algorithm. [ Time Frame: 3 days ]
Phase III open Study, multicenter, prospective, randomized entrance of a total of 188 patients, 94 patients will receive medication test and 94 patients will receive Otosynalar®.
Patients will be assessed until the clinical condition has been resolved or a maximum of 3 days.
188 patients of either gender or race, who have at least two of the following symptoms: pain, discharge, tinnitus, ear fullness, subjective hearing loss temporary dizziness or vertigo. And with a clinical or non-acute external otitis.